Abstract:Abstract 4815 Introduction: Acute myeloid leukemia (AML) is the most common type of adult leukemia for which cytosine arabinoside(Ara-C)-based chemotherapy is the main treatment. However, there is a significant difference in treatment response and survival, especially among large groups of patients with the same disease classification. Single nucleotide polymorphisms within the nucleotide excision repair pathway may alter the susceptibility of leukemia cells to chemotherapy. We investigated the role of six single nucleotide polymorphisms (ERCC5rs76871136, ERCC5rs77569659, ERCC5rs873601, XPCrs2228000, XPCrs2228001, and XPCrs1870134) within the nucleotide excision repair pathway on the outcome of patients with AML treated with cytosine arabinoside-based chemotherapy. Methods: One hundred fifty-one patients with AML in a Chinese population were enrolled in this study. Patients diagnosed with other cancers or other hematological malignancies were excluded in this study. This study was approved by the ethics committee of Southeast University in compliance with Chinese guidelines for blood donation, and informed consent for genetic analysis was obtained from all participants according to the Declaration of Helsinki. All patients received Ara-C-based standard induction chemotherapy regimens. Patients were divided into three groups, according to cytogenetic risk. Moreover, the evaluation standard of these patients were evaluated by age(£40 years, 40–60 years, and 360 years), WBC (>50 ′ 109/L vs. £50 ′ 109/L), hemoglobin level (>100 g/L vs. £100 g/L), and platelet count (>60 ′ 109/L vs. £60 ′ 109/L). Genotypes were determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Deviations from the Hardy–Weinberg equilibrium for genotypes and haplotype frequencies as well as haplotype–trait associations were assessed with Pearson's c2 analysis using SHEsis. Once the expected number in any cell was less than five, demographic and clinical data across genotypes were compared using Pearson's c2analysis or Fisher's exact test. Significant genotypic differences among the different responders were calculated using Pearson's c2analysis. P <0.05 was considered statistically significant. We estimated the relative risk of responding to treatment with the genotypes as odds ratio(OR) and 95% confidence intervals(95%CI) using conditional logistic regression with adjustment for the effects of covariates. All statistical tests were two-sided and performed using SPSS 17.0. Results: Genotype frequencies for the polymorphisms were found to be in Hardy–Weinberg equilibrium. The results indicated that the distribution of three genotypes of XPCrs1870134 significantly differed among the cytogenetic risk groups (P = 0.04). The frequency of the CC genotype of XPCrs2228001 was significantly higher in male patients than in female patients (P = 0.03), whereas that of the CC genotype of XPCrs2228000 was significantly higher in patients with a hemoglobin level of 100 g/L or less compared with those who had a hemoglobin level greater than 100 g/L (P = 0.039).Moreover, patients carrying at least one variant allele (XPCrs2228001AA+CC) were more likely to respond better than those who did not carry a variant. However, no significant association was detected between polymorphisms in ERCC5 and treatment response. Conclusions: These findings suggest that XPC polymorphisms are important markers for the outcome of patients with AML in the Chinese population. Disclosures: No relevant conflicts of interest to declare.

The Effect of Genetic Factor on Mechanism for Drug-Resistance of CYP3A5 in Acute Leukemia.

Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis]

[Expression of CYP3A5 Mrna in Children with Acute Leukemia].

Study on the Phenotype Polymorphism of Cyp3a4 Gene in Chinese Children with Acute Leukemia.

Progress in research of cytochrome P450 3A4 gene polymorphism

The Correlation Between Cyp3a4 Genetic Polymorphism and Children with Acute Leukemia.

Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia

Effect of SLC29A1 polymorphism G-706C on clinical outcomes of cytarabine-containing chemotherapy for acute myeloid leukemia patients

The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines]

Genetic polymorphisms of CYP1A1 and CYP2D6 and their impact on leukemia morbidity

The Relationship Between CYP3A5*3 Polymorphism and Drug Adverse Reaction of Pediatric Acute Leukemia

P5-19-07: the Effects of ABCC2 and SLCO1B3 Single Nucleotide Polymorphisms on Docetaxel-Induced Leukopenia in Breast Cancer Patients.

Polymorphisms in XPC Provide Prognostic Information in Acute Myeloid Leukemia

Relationship between ectopic expression of multidrug resistance-related proteins and clinical efficacy and prognosis in acute leukemia

Association of Polymorphisms of Cytosine Arabinoside-Metabolizing Enzyme Gene with Therapeutic Efficacy for Acute Myeloid Leukemia

[Study on the Relationship Between Polymorphisms of Cyp1A1, GSTM1, GSTT1 Genes and the Susceptibility to Acute Leukemia in the General Population of Hunan Province].

Effect of CYP3A5 genetic polymorphism on blood drug concentration and efficacy of tacrolimus in Chinese renal transplant recipients

The Influence of Cytidine Deaminase -33Delc Polymorphism on Treatment Outcome with High-Dose Cytarabine in Chinese Patients with Relapsed Acute Myeloid Leukaemia

E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia

[Polymorphisms of RAD51(G135C) and XRCC3(C241T) Genes and Correlations Thereof with Prognosis and Clinical Outcomes of Acute Myeloid Leukemia].

Association Between CYP2B6 Polymorphism and Acute Leukemia in a Han Population of Northwest China